CX-2051

· CytomX Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CX-2051, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: First In Human Study of CX-2051 in Advanced Solid Tumors [Phase 1]